M1 Kliniken AG
XETRA:M12
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.04
21.9
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
M1 Kliniken AG
M1 Kliniken AG
Cash & Cash Equivalents
M1 Kliniken AG
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
M1 Kliniken AG
XETRA:M12
|
Cash & Cash Equivalents
€10.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Cash & Cash Equivalents
€299.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-18%
|
|
|
Mediclin AG
XETRA:MED
|
Cash & Cash Equivalents
€130m
|
CAGR 3-Years
5%
|
CAGR 5-Years
35%
|
CAGR 10-Years
18%
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Cash & Cash Equivalents
€3.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Cash & Cash Equivalents
€2.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
M
|
MedNation AG
SWB:EIF
|
Cash & Cash Equivalents
€2.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
M1 Kliniken AG
Glance View
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
See Also
What is M1 Kliniken AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
10.3m
EUR
Based on the financial report for Jun 30, 2024, M1 Kliniken AG's Cash & Cash Equivalents amounts to 10.3m EUR.
What is M1 Kliniken AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-8%
Over the last year, the Cash & Cash Equivalents growth was -56%. The average annual Cash & Cash Equivalents growth rates for M1 Kliniken AG have been -30% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
